- Oculus Innovative Sciences (OCLS) FQ4 results: Revenues: $3.5M (-12.5%); R&D Expense: $0.4M (+18.9%); SG&A: $4.1M (+24.2%); Net Loss: ($2.9M) (-93.3%); Loss Per Share: ($0.16) (-45.5%).
- FY2016 results: Revenues: $15.1M (+8.6%); R&D Expense: $1.8M (+20.0%); SG&A: $15.6M (+25.8%); Net Loss: ($10.2M) (-24.4%); Loss Per Share: ($0.62) (+27.1%); Quick Assets: $7.5M (+23.0%).
- No guidance given.
Oculus Innovative Sciences FY16 revenues up 9%
Recommended For You
More Trending News
About SNOA Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SNOA | - | - |
Sonoma Pharmaceuticals, Inc. |